Business
Here’s why the Rhythm Bioscience (ASX:RHY) share price is up 15% to a record high
The Rhythm Biosciences Ltd (ASX: RHY) share price has continued its positive run on Tuesday.
At one stage, the medical device company’s shares were up 15% to a record high of $1.30.
This is almost 1,000% higher than this time last year, making it a “ten-bagger” for investors.
Why is the Rhythm Biosciences share price on fire?
Investors have been buying the company’s shares since the release of two positive announcements in December.
The first announcement revealed that Rhythm Bioscience has appointed France-based Biotem as the global manufacturer of its ColoSTAT test-kit.
ColoSTAT is Rhythm’s lead product and is intended to be a simple, affordable, minimally invasive, and effective blood test for the early detection of…
-
Noosa News13 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General23 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Business22 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News24 hours agoUrgent recall notice issued for deli meats over contamination risk